$API

Insider activity reported for several US public companies. Agora's CEO bought $168,304 in shares, Rapport Therapeutics saw two directors buy shares totaling $346,168, Corebridge Financial's 10% owner bought $6.77M, and BNY Mellon Strategic Municipals had a director buy $262,611. Sells included United Therapeutics' CEO selling $5.32M, Innsuites' CEO selling $2.01B, Arista Networks' CTO selling $7.84M, Lindblad Expeditions' director selling $8.64M, and Braze's CTO selling $13.22M.

Zhao Bin (Chief Executive Officer) purchased 38,267 indirectly-held shares of Agora, Inc. (API) at an average of $4.40 ($4.36–$4.46, $0.17M total) across 4 trades over 2026-10-19 to 2026-10-22 under a Rule 10b5-1 trading plan.

Zhao Bin (Chief Executive Officer) purchased 24,132 indirectly-held shares of Agora, Inc. (API) at an average of $4.21 ($4.11–$4.30, $0.10M total) across 3 trades over 2026-10-12 to 2026-10-14 under a Rule 10b5-1 trading plan.

Zhao Bin (Chief Executive Officer) purchased 167,385 indirectly-held shares of Agora, Inc. (API) at an average of $4.16 ($3.98–$4.33, $0.70M total) across 18 trades over 2026-09-16 to 2026-10-09 under a Rule 10b5-1 trading plan.

Three Nasdaq-listed stocks under $10 are highlighted: Ericsson (ERIC) at $9.42, Agora (API) at $4.15, and Grab (GRAB) at $3.10. Ericsson offers dividends and buybacks, Agora shows consistent profits, and Grab reports strong growth and buybacks. Each has specific risks and analyst targets.

Agora, Inc. (NASDAQ: API) is showcasing its Conversational AI Platform for Physical AI at IFA 2026, introducing Voiceprint, Voice Cloning, and Model Context Protocol (MCP) capabilities. These features enable devices to recognize users, create personalized voices, and access external services. The company will demonstrate its technology across various devices and partners at the event.

API Holdings, parent of Thyrocare, repaid its outstanding term debt of ₹1,050 crore using proceeds from selling part of its Thyrocare stake and internal accruals, making the group debt-free. Docon Technologies sold 9.90% of Thyrocare shares, keeping a 51.02% stake. The debt-linked pledge on remaining Thyrocare shares was released.

Agora, Inc. (API) furnished an SEC Form 6-K — earnings release. Agora, Inc. Reports Second Quarter 2026 Financial Results SANTA CLARA, Calif., August 13, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial res

Agora (NASDAQ:API) said CEO and founder Tony Zhao notified its board that he plans to buy up to $20M of Agora American depositary shares or Class A ordinary shares over the next 12 months, subject to rules and the company’s insider-trading policy. Separately, BofA analyst Daley Li cut its price target to $6.60 from $7.10 while keeping a Buy rating after Q1 results. Agora reported Q1 revenue of $37.7M, up from $33.3M.

Agora Inc. (NASDAQ:API) reported Q1 2026 revenue of $37.7 million, up 13.5% year over year, and GAAP net profit of $1.1 million, more than double Q1 2025, according to the company. It launched Agent Studio and expanded conversational AI. Agora forecast Q2 2026 revenue of $39–$40 million and said it expects AI to contribute ~5% of revenue by year-end.